Introduction to the Special Track on Artificial Intelligence and COVID-19

The human race is facing one of the most meaningful public health emergencies in the modern era caused by the COVID-19 pandemic. This pandemic introduced various challenges, from lock-downs with significant economic costs to fundamentally altering the way of life for many people around the world. The battle to understand and control the virus is still at its early stages yet meaningful insights have already been made. The uncertainty of why some patients are infected and experience severe symptoms, while others are infected but asymptomatic, and others are not infected at all, makes managing this pandemic very challenging. Furthermore, the development of treatments and vaccines relies on knowledge generated from an ever evolving and expanding information space. Given the availability of digital data in the modern era, artificial intelligence (AI) is a meaningful tool for addressing the various challenges introduced by this unexpected pandemic. Some of the challenges include: outbreak prediction, risk modeling including infection and symptom development, testing strategy optimization, drug development, treatment repurposing, vaccine development, and others. © 2023 AI Access Foundation. All rights reserved.

Predicting COVID-19 Patient Shielding: A Comprehensive Study

There are many ways machine learning and big data analytics are used in the fight against the COVID-19 pandemic, including predictions, risk management, diagnostics, and prevention. This study focuses on predicting COVID-19 patient shielding—identifying and protecting patients who are clinically extremely vulnerable from coronavirus. This study focuses on techniques used for the multi-label classification of medical text. Using the information published by the United Kingdom NHS and the World Health Organisation, we present a novel approach to predicting COVID-19 patient shielding as a multi-label classification problem. We use publicly available, de-identified ICU medical text data for our experiments. The labels are derived from the published COVID-19 patient shielding data. We present an extensive comparison across 12 multi-label classifiers from the simple binary relevance to neural networks and the most recent transformers. To the best of our knowledge this is the first comprehensive study, where such a range of multi-label classifiers for medical text are considered. We highlight the benefits of various approaches, and argue that, for the task at hand, both predictive accuracy and processing time are essential. © 2022, Springer Nature Switzerland AG.